459 related articles for article (PubMed ID: 26997382)
1. Multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in patients with chronic kidney disease stages 4, 5, and 5D: The OCEANOS study.
Shaheen FA; Kurpad R; Al-Sayyari AA; Souqiyyeh MZ; Aljubori H; El Baz T; Kashif W; Tuganbekova S; Kabulbayev K; Jarraya F; Nafar M
Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):290-304. PubMed ID: 26997382
[TBL] [Abstract][Full Text] [Related]
2. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.
Gallieni M; De Luca N; Santoro D; Meneghel G; Formica M; Grandaliano G; Pizzarelli F; Cossu M; Segoloni G; Quintaliani G; Di Giulio S; Pisani A; Malaguti M; Marseglia C; Oldrizzi L; Pacilio M; Conte G; Dal Canton A; Minutolo R
J Nephrol; 2016 Feb; 29(1):71-8. PubMed ID: 25986389
[TBL] [Abstract][Full Text] [Related]
3. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
[TBL] [Abstract][Full Text] [Related]
4. Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countries.
Al Rukhaimi M; Al Sahow A; Boobes Y; Goldsmith D; Khabouth J; El Baz T; Mahmoud H; Ganji MR; Shaheen FA;
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):133-48. PubMed ID: 24434398
[TBL] [Abstract][Full Text] [Related]
5. Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
Manns BJ; Hodsman A; Zimmerman DL; Mendelssohn DC; Soroka SD; Chan C; Jindal K; Klarenbach S
Am J Kidney Dis; 2010 May; 55(5):800-12. PubMed ID: 20438984
[No Abstract] [Full Text] [Related]
6. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
7. Trends of elevated parathormone serum titers in hemodialysis patients on intensive therapy for bone disease: a multicenter study.
Karkar A; Sinha AK; Abdelrahman M; Mushtaque F; Awn NM; Qadi Y; Nassar M; Algareeb A; Taha MI; Abdulkader M; Sabry A; Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1166-77. PubMed ID: 25394432
[TBL] [Abstract][Full Text] [Related]
8. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
Ennis JL; Worcester EM; Coe FL; Sprague SM
J Nephrol; 2016 Feb; 29(1):63-70. PubMed ID: 25736620
[TBL] [Abstract][Full Text] [Related]
9. Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children.
Wesseling-Perry K; Salusky IB
Pediatr Nephrol; 2013 Apr; 28(4):617-25. PubMed ID: 23381010
[TBL] [Abstract][Full Text] [Related]
10. Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters.
Roetker NS; Peng Y; Ashfaq A; Gilbertson DT; Wetmore JB
Am J Nephrol; 2019; 49(3):225-232. PubMed ID: 30820015
[TBL] [Abstract][Full Text] [Related]
11. Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study.
Ennis J; Gillen D; Rubenstein A; Worcester E; Brecher ME; Asplin J; Coe F
BMC Nephrol; 2015 Oct; 16():163. PubMed ID: 26471846
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic interventions for chronic kidney disease-mineral and bone disorders: focus on mortality.
Block GA
Curr Opin Nephrol Hypertens; 2011 Jul; 20(4):376-81. PubMed ID: 21519253
[TBL] [Abstract][Full Text] [Related]
13. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
Jean G; Daugas É; Roth H; Drueke T; Bouchet JL; Hannedouche T; London G; Fouque D
Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391
[TBL] [Abstract][Full Text] [Related]
14. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
[TBL] [Abstract][Full Text] [Related]
15. Phosphate binders in moderate chronic kidney disease: where do we stand?
Bellasi A; Cozzolino M; Adragao T; Di Iorio B; Russo D
J Nephrol; 2013; 26(6):993-1000. PubMed ID: 23543481
[TBL] [Abstract][Full Text] [Related]
16. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients.
Einbinder Y; Benchetrit S; Golan E; Zitman-Gal T
Ann Lab Med; 2017 Sep; 37(5):381-387. PubMed ID: 28643486
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic guidelines fulfillment in clinical practice in patients with chronic kidney disease (CKD)].
Verdalles U; García de Vinuesa S; Goicoechea M; Gómez Campderá F; Luño J
Nefrologia; 2007; 27(3):320-8. PubMed ID: 17725451
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: results of the OSERCE study.
Górriz JL; Molina P; Bover J; Barril G; Martín-de Francisco AL; Caravaca F; Hervás J; Piñera C; Escudero V; Molinero LM;
Nefrologia; 2013 Jan; 33(1):46-60. PubMed ID: 23364626
[TBL] [Abstract][Full Text] [Related]
20. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
Panawong W; Chaiyakum A; Pongskul C
J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
